Virtus ETF Advisers’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,893
| Closed | -$105K | – | 497 |
|
|
2022
Q1 | $105K | Sell |
3,893
-238
| -6% | -$6.42K | 0.05% | 294 |
|
|
2021
Q4 | $197K | Buy |
4,131
+1,396
| +51% | +$66.6K | 0.07% | 215 |
|
|
2021
Q3 | $182K | Sell |
2,735
-145
| -5% | -$9.65K | 0.08% | 295 |
|
|
2021
Q2 | $225K | Buy |
2,880
+514
| +22% | +$40.2K | 0.09% | 261 |
|
|
2021
Q1 | $224K | Buy |
2,366
+33
| +1% | +$3.12K | 0.09% | 310 |
|
|
2020
Q4 | $284K | Sell |
2,333
-2,701
| -54% | -$329K | 0.12% | 240 |
|
|
2020
Q3 | $440K | Sell |
5,034
-694
| -12% | -$60.7K | 0.23% | 152 |
|
|
2020
Q2 | $370K | Sell |
5,728
-770
| -12% | -$49.7K | 0.18% | 238 |
|
|
2020
Q1 | $290K | Sell |
6,498
-946
| -13% | -$42.2K | 0.12% | 226 |
|
|
2019
Q4 | $464K | Buy |
+7,444
| New | +$464K | 0.08% | 212 |
|